+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Topical Wound Agents Market by Product, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4896813
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Topical Wound Agents Market grew from USD 2.61 billion in 2023 to USD 2.89 billion in 2024. It is expected to continue growing at a CAGR of 10.99%, reaching USD 5.42 billion by 2030.

Topical wound agents, encompassing creams, ointments, gels, and sprays, cater to the treatment and management of various wound types, such as chronic and acute wounds, burns, and post-surgical wounds. These agents serve the critical purpose of infection prevention, enhancement of wound healing, and pain management, making them crucial in healthcare settings, homecare, and military applications. Hospitals, clinics, home healthcare setups, and specialty wound care centers represent the end-use spectrum. The market growth is notably driven by an aging global population, rising incidences of diabetes, and increasing surgical procedures, which elevate the demand for efficient wound care solutions. Furthermore, heightened awareness around wound care management and the development of advanced wound care products, such as bioactive and antimicrobial agents, are propelling market expansion. Emerging opportunities include leveraging nanotechnology and biomaterials for developing sophisticated wound care solutions with enhanced efficacy and fewer side effects. However, the sector faces challenges, including high costs associated with advanced wound care products, reimbursement issues, and stringent regulatory frameworks, hindering market penetration and growth. Research and innovation could focus on developing cost-effective, durable, and multifunctional wound care products that incorporate natural and sustainable materials. Exploring personalized medicine approaches through tailored wound care solutions or integrating digital health technologies for real-time wound monitoring can provide competitive advantages. Companies could also benefit from strengthening distribution networks, particularly in emerging markets where healthcare infrastructure is improving, but access to advanced wound care remains limited. Maintaining a focus on consumer education to enhance the adoption of innovative wound care technologies can aid business growth. The market is moderately competitive, with key players investing in product innovation and strategic partnerships to capture a larger market share, necessitating continual innovation and adaptation to emerging trends for sustained growth.

Understanding Market Dynamics in the Topical Wound Agents Market

The Topical Wound Agents Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing incidence of acute and chronic wounds globally
    • Increasing cases of road accidents and traumatic events
    • Rising government initiatives to increase awareness on wound infections
  • Market Restraints
    • Concerns pertinent to antibiotics
  • Market Opportunities
    • Ongoing introduction of technologically advanced products
    • Emergence of smart wound care and digital health
  • Market Challenges
    • Strict regulatory process for approval

Exploring Porter’s Five Forces for the Topical Wound Agents Market

Porter’s Five Forces framework further strengthens the insights of the Topical Wound Agents Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Topical Wound Agents Market

External macro-environmental factors deeply influence the performance of the Topical Wound Agents Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Topical Wound Agents Market

The Topical Wound Agents Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Topical Wound Agents Market

The Topical Wound Agents Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Topical Wound Agents Market

The Topical Wound Agents Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Wound Agents Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, DUKAL LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kerecis, Medtronic PLC, Mylan N.V., Mölnlycke Health Care AB, Novartis International AG, Pfizer, Inc., Smith & Nephew PLC, Swiss-American CDMO, Teva Pharmaceutical Industries Ltd, Themis Medicare Ltd, and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Wound Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Cream
    • Gel
    • Spray
  • Application
    • Acute Wound
      • Burn
      • Surgical & Traumatic Wound
    • Chronic Wound
      • Diabetic Foot Ulcer
      • Pressure Ulcer
      • Venous Leg Ulcer
  • End User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of acute and chronic wounds globally
5.1.1.2. Increasing cases of road accidents and traumatic events
5.1.1.3. Rising government initiatives to increase awareness on wound infections
5.1.2. Restraints
5.1.2.1. Concerns pertinent to antibiotics
5.1.3. Opportunities
5.1.3.1. Ongoing introduction of technologically advanced products
5.1.3.2. Emergence of smart wound care and digital health
5.1.4. Challenges
5.1.4.1. Strict regulatory process for approval
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Topical Wound Agents Market, by Product
6.1. Introduction
6.2. Cream
6.3. Gel
6.4. Spray
7. Topical Wound Agents Market, by Application
7.1. Introduction
7.2. Acute Wound
7.2.1. Burn
7.2.2. Surgical & Traumatic Wound
7.3. Chronic Wound
7.3.1. Diabetic Foot Ulcer
7.3.2. Pressure Ulcer
7.3.3. Venous Leg Ulcer
8. Topical Wound Agents Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Topical Wound Agents Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Topical Wound Agents Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Topical Wound Agents Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. TOPICAL WOUND AGENTS MARKET RESEARCH PROCESS
FIGURE 2. TOPICAL WOUND AGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. TOPICAL WOUND AGENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. TOPICAL WOUND AGENTS MARKET DYNAMICS
TABLE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY BURN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SURGICAL & TRAUMATIC WOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 43. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 44. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 48. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 49. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 70. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 71. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 75. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 76. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 85. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 86. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 115. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 116. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 131. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 132. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 136. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 137. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 141. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 142. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 146. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 147. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 151. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 152. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 161. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 162. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 176. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 177. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 181. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 182. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 186. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 187. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 206. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 207. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 221. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 222. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Topical Wound Agents Market, which are profiled in this report, include:
  • AstraZeneca PLC
  • DUKAL LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kerecis
  • Medtronic PLC
  • Mylan N.V.
  • Mölnlycke Health Care AB
  • Novartis International AG
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Swiss-American CDMO
  • Teva Pharmaceutical Industries Ltd
  • Themis Medicare Ltd
  • Vericel Corporation

Methodology

Loading
LOADING...

Table Information